1,335
Views
0
CrossRef citations to date
0
Altmetric
Review

A review on the effects of vitamin D attenuating ischemia reperfusion injuries

ORCID Icon, ORCID Icon, , &
Pages 522-540 | Received 19 Aug 2021, Accepted 07 Mar 2022, Published online: 27 Mar 2022

References

  • Burak, A.; Cenk, C.; Fahrettin, K.; Kamil, G.; Fatih, A.; Ertuğrul, O.; Murat, B. Barıs O.The Relationship between Grade of Ischemia, Success of Reperfusion, and Type of Thrombolytic Regimen. Med. Sci. Monit. 2015, 21(3), 716–721. DOI: 10.12659/MSM.892645.
  • Christina, M. ; Lukas, G.; Peter, S.; Bettina, L.; Philipp, S. Combating Ischemia-Reperfusion Injury with Micronutrients and Natural Compounds during Solid Organ Transplantation: Data of Clinical Trials and Lessons of Preclinical Findings. Int. J. Mol. Sci. 2021, 22(19), 10675. DOI: 10.3390/ijms221910675.
  • Georgios, M; Alkistis, K; Michael, P; Anna, P; Dimitris, A; Anastasios, M; Theodoros, L; Konstantinos, M; Spyros, V; Andreas, M. L. Remote Ischemic Preconditioning Decreases the Magnitude of Hepatic Ischemia-Reperfusion Injury on a Swine Model of Supraceliac Aortic Cross-Clamping. Ann. Vasc. Surg. 2018, 48(4), 241–250. DOI: 10.1016/j.avsg.2017.08.006.
  • Efstathios, K. I.; Ioannis, A. P.; Katerina, F.; Dimitrios, F.; Ioanna, A.; Aias, A.; Ignatios, I.; Dionyssios, L.; Dimitrios, T. K. Staccato Reperfusion Prevents Reperfusion Injury in Patients Undergoing Coronary Angioplasty: A 1-year Follow-up Pilot Study. Atherosclerosis. 2009, 204(2), 497–502. DOI: 10.1016/j.atherosclerosis.2008.09.037.
  • Eltzschig, H. K; Collard, C. D. Vascular Ischaemia and Reperfusion Injury. Br. Med.Bull. 2004, 70, 71–86. DOI: 10.1093/bmb/ldh025.
  • Eltzschig, H. K.; Eckle, T. Ischemia and Reperfusion–from Mechanism to Translation. Nat. Med. 2011, 17(11), 1391–1401. DOI: 10.1038/nm.2507.
  • Stephenson, D.; Yin, T.; Smalstig, E. B.; Hsu, M. A.; Panetta, J.; Little, S.; Clemens, J. Transcription Factor Nuclear Factor-kappa B Is Activated in Neurons after Focal Cerebralischemia. J. Cerebr. Blood. F. Met. 2000, 20(3), 592–603. DOI: 10.1097/00004647-200003000-00017.
  • Ravingerova, T; Farkasova, V; Griecsova, L; Carnicka, S; Murarikova, M; Barlaka, E; Kolar, F; Bartekova, M; Lonek, L; Slezak, J, et al. Remote Preconditioning as a Novel“Conditioning” Approach to Repair the Broken Heart: Potential Mechanisms and ClinicalApplications. Physiological Research. 2016, 65, S55–S64. DOI: 10.33549/physiolres.933392.
  • Liao, Z; Liu, D; Tang, L; Yin, D; Yin, S; Lai, S; Yao, J; He, M. Long-term Oral Resveratrol in Take Provides Nutritional Preconditioning against Myocardial Ischemia /Reperfusion Injury:involvement of VDAC1 Downregulation. Mol. Nutr. Food. Res. 2015, 59(3), 454–464. DOI: 10.1002/mnfr.201400730.
  • Chen, C; Zhou, X; He, J; Xie, Z; Xia, S; Lu, G. The Roles of GABA in Ischemia-Injury in the Central Nervous System and Peripheral Organs. Oxid.Med.Cell.Longev. 2019, 2019, 4028394. DOI: 10.1155/2019/4028394.
  • Zuniga, J.; Cancino, M.; Medina, F.; Varela, P.; Vargas, R.; Tapia, G.; Videla, L. A.; Fernandez, V. N-3 PUFA Supplementation Triggers PPAR-alpha Activation and PPAR-alpha/ NF-kappaBinteraction:anti-inflammatory Implications in Liver Ischemia-reperfusion Injury. PLoS One. 2011, 6(12), e28502. DOI: 10.1371/journal.pone.0028502.
  • Dorland’s Illustrated Medical Dictionary uVToV. 2011, 32 edition.
  • Roseland, J. M. P. K; Patterson, K. Y; Pehrsson, P. R, and Taylor, C. L. Vitamin D in Foods: Anevolution of Knowledge. In Vitamin D, Volume 2: Health, Disease and Therapeutics, FourthEdition; Feldman, D., Pike, J. W., Bouillon, R., Giovannucci, E., Goltzman, D., Hewison, M., Eds.; British: Elsevier, 2018; pp 41–78.
  • Jones, G. Vitamin D. In ModernNutrition in Health and Disease 11th; CB, R. A. C., Cousins, R. J., Tucker, K. L., Ziegler, T. R. Eds.; Lippincott Williams & Wilkins: Philadelphia, 2014.
  • Institute of Medicine. National Academy Press: FaNBDRIfCaVDW, DC, 2010.
  • Adams, J. S.; Hewison, M. Update in Vitamin D. J. Clin. Endocrinol. Metab. 2010, 95(2), 471–478. DOI: 10.1210/jc.2009-1773.
  • Wang, T.; Bengtsson, G.; Kärnefelt, I.; L.o, B. Provitamins and Vitamins D₂ and D₃ in Cladina Spp. Over a Latitudinal Gradient: Possible Correlation with UV Levels. J. Photochem. Photobiol. B: Biol. 2001, 62(1–2), 118–122. DOI: 10.1016/S1011-1344(01)00160-9.
  • IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of Vitamin D. Recommendations 1981”. Eur.J. Biochem. 1982, 124(2), 223–227.
  • Barbarawi, M; Kheiri, B; Zayed, Y; Barbarawi, O; Dhillon, H; Swaid, B; Yelangi, A; Sundus, S; Bachuwa, G; Alkotob, M. L. :., et al. Vitamin D Supplementation andCardiovascular Disease Risks inMore than 83000 Individuals in 21 Randomized ClinicalTrials: A Meta-analysis. JAMA. Cardiol. 2019, 4(8), 765–776. DOI: 10.1001/jamacardio.2019.1870.
  • Sintzel, M. B.; Rametta, M.; Reder, A. T. Vitamin D and Multiple Sclerosis: A ComprehensiveReview. Neurol. Ther. 2018, 7(1), 59–85. DOI: 10.1007/s40120-017-0086-4.
  • Seida, J. C.; Mitri, J.; Colmers, I. N.; Majumdar, S. R.; Davidson, M. B.; Edwards, A. L.; Hanley, D. A.; Pittas, A. G.; Tjosvold, L.; Johnson, J. A. Clinical Review: Effect of Vitamin D3supplementation on Improving Glucose Homeostasis and Preventing Diabetes: A Systematicreview and Meta-analysis. J. Clin. Endocrinol. Metab. 2014, 99(10), 3551–3560. DOI: 10.1210/jc.2014-2136.
  • Byers, T. Anticancer Vitamins du Jour–The ABCED’s so Far. Am.J .Epidemiol. 2010, 172(1), 1–3. DOI: 10.1093/aje/kwq112.
  • Bivona, G; Gambino, C. M; Iacolino, G; Ciaccio, M. Vitamin D and the Nervoussystem. Neurol.Res. 2019, 41(9), 827–835. DOI: 10.1080/01616412.2019.1622872.
  • Holick, M. F. The Vitamin D Deficiency Pandemic: Approaches for Diagnosis,treatmentand Prevention. Rev. Endocr. Metab. Disord. 2017, 18(2), 153–165. DOI: 10.1007/s11154-017-9424-1.
  • Raisi-Estabragh, Z; Martineau, A. R; Curtis, E. M; Moon, R. J; Darling, A; Lanham-New, S; Ward, K. A; Cooper, C; Munroe, P. B; Petersen, S. E, et al. Vitamin D Andcoronavirusdisease2019 (COVID-19): Rapid Evidence Review. Aging. Clin. Exp. Res. 2021, 33(7), 2031–2041. DOI: 10.1007/s40520-021-01894-z.
  • Tecilazich, F.; Formenti, A. M.; Giustina, A. Role of Vitamin D in Diabetic retinopathy:Pathophysiologicaland Clinical Aspects. Rev. Endocr. Metab. Disord. 2020, 10, 1–13.
  • Bouillon, R; Carmeliet, G; Verlinden, L; van Etten, E; Verstuyf, A; Luderer, H. F; Lieben, L; Mathieu, C; Demay, M. Vitamin D and Human Health: Lessons from Vitamin D Receptornull Mice. Endocr. Rev. 2008, 29(6), 726–776. DOI: 10.1210/er.2008-0004.
  • Hii, C. S.; Ferrante, A. The Non-Genomic Actions of Vitamin. D.Nutrients. 2016, 8(3), 135. DOI: 10.3390/nu8030135.
  • Wang, Y. J; Zhu, J. G; DeLuca, H. F. Where Is the Vitamin D Receptor? Archives ofBiochemistryandBiophysics. 2012, 523(1), 123–133.
  • Marino, R; Misra, M. Extra-Skeletal Effects of Vitamin D. Nutrients. 2019, 11(7), 1460. DOI: 10.3390/nu11071460.
  • Ross, A. C.; Taylor, C. L.; Yaktine, A. L., and Del Valle, H. B. In Dietary ReferenceIntakes forCalcium and Vitamin D. The National Academies Collection: Reports Funded by NationalInstitutes of Health. 2011. Eds. Washington, (DC): The National Press.
  • Giustina, A.; Adler, R. A.; Binkley, N.; Bouillon, R.; Ebeling, P. R.; Lazaretti-Castro, M.; Marcocci, C.; Rizzoli, R.; Sempos, C. T.; Bilezikian, J. P. Controversies in Vitamin D:Summary Statement from an International Conference. J. Clin.Endocrinol. Metab. 2019, 104(2), 234–240. DOI: 10.1210/jc.2018-01414.
  • Rosen, C. J.; Abrams, S. A.; Aloia, J. F.; Brannon, P. M.; Clinton, S. K.; Durazo-Arvizu, R. A.; Gallagher, J. C.; Gallo, R. L.; Jones, G.; Kovacs, C. S., et al. IOM Committee Members Respond to Endocrine Societyvitamin D Guideline. J. Clin. Endocrinol. Metab. 2012, 97(4), 1146–1152. DOI: 10.1210/jc.2011-2218.
  • Chalcraft, J. R.; Cardinal, L. M.; Wechsler, P. J.; Hollis, B. W.; Gerow, K. G.; Alexander, B. M.; Keith, J. F.; Larson-Meyer, D. E. Vitamin D Synthesis following a SingleBoutof SunExposure in Older and Younger Men and Women. Nutrients. 2020, 12(8), 2237. DOI: 10.3390/nu12082237.
  • Brown, L. L; Cohen, B; Tabor, D; Zappala, G; Maruvada, P; Coates, P. M. The Vitamin Dparadox in Black Americans: A Systems-based Approach to Investigating Clinical Practice,research, and Public Health - Expert Panel Meeting Report. BMC.Proc. 2018, 12(Suppl 6), 6. DOI: 10.1186/s12919-018-0102-4.
  • Bouillon, R; Marcocci, C.; Carmeliet, G.; Bikle, D; White, J. H; Dawson-Hughes, B.; Lips, P.; Munns, C. F.; Lazaretti-Castro, M.; Giustina, A., et al. Skeletal and ExtraskeletalActions of Vitamin D: Current Evidence and Outstanding Questions. Endocr. Rev. 2019, 40(4), 1109–1151. DOI: 10.1210/er.2018-00126.
  • Galior, K; Grebe, S; Singh, R. Development of Vitamin D Toxicity from Overcorrection of Vitamin D Deficiency: A Review of Case Reports. Nutrients. 2018, 10(8), 953. DOI: 10.3390/nu10080953.
  • Vogiatzi, M. G; Jacobson-Dickman, E; DeBoer, M. D. Drugs, Therapeutics Committee ofThe Pediatric Endocrine S: Vitamin D Supplementation and Risk of Toxicity in PediatricS: Areview of Current Literature. J.Clin. Endocrinol.Metab. 2014, 99(4), 1132–1141. DOI: 10.1210/jc.2013-3655.
  • Ross, A. C.; Manson, J. E.; Abrams, S. A.; Aloia, J. F.; Brannon, P. M.; Clinton, S. K.; Durazo-Arvizu, R. A.; Gallagher, J. C.; Gallo, R. L.; Jones, G., et al. The 2011 Report on Dietary Referenceintakes for Calcium and Vitamin D from theInstitute of Medicine: What Clinicians Need to Know. J. Clin. Endocrinol. Metab. 2011, 96(1), 3–58. DOI: 10.1210/jc.2010-2704.
  • Shimokawa, H.; Yasuda, S. Myocardial Ischemia: Current Concepts and Future Perspectives. J. Cardiol. 2008, 52(2), 67–78. DOI: 10.1016/j.jjcc.2008.07.016.
  • Fishbeina, G. A.; Fishbeina, M. C., and Buja, L. M. Cardiovascular Pathology. 4th. Academic Press; 2016. Chapter 7 - Myocardial Ischemia and Its Complications; pp. 239–270., 2016.
  • Basalay, M. V.; Yellon, D. M.; Davidson, S. M. Targeting Myocardial Ischaemic Injuryin the Absence of Reperfusion. Basic. Res. Cardiol. 2020, 115(5), 63. DOI: 10.1007/s00395-020-00825-9.
  • Heusch, G. Myocardial Ischaemia-reperfusion Injury and Cardioprotection in Perspective. Nat. Rev. Cardiol. 2020, 17(12), 773–789. DOI: 10.1038/s41569-020-0403-y.
  • Zhang, C; He, M; N,i, L.; He, K; Su, K; Deng, Y; Li, Y; Xia, H. The Role of ArachidonicAcid Metabolism in Myocardial Ischemia-Reperfusion Injury. Cell. Biochem. Biophys. 2020, 78(3), 255–265. DOI: 10.1007/s12013-020-00928-z.
  • Muscogiuri, G; Annweiler, C; Duval, G; Karras, S; Tirabassi, G; Salvio, G; Balercia, G.; Kimball, S.; Kotsa, K.; Mascitelli, L., et al. Vitamin D Andcardiovascular Disease: From Atherosclerosis to Myocardial Infarction and Stroke. Int. J.Cardiol. 2017, 230, 577–584. DOI: 10.1016/j.ijcard.2016.12.053.
  • Rai, V; Agrawal, D. K. Role of Vitamin D in Cardiovascular Diseases. Endocrinol. Metab.Clin. North. Am. 2017, 46(4), 1039–1059. DOI: 10.1016/j.ecl.2017.07.009.
  • Bouillon, R. Vitamin D and Cardiovascular Disorders. Osteoporos. Int. 2019, 30(11), 2167–2181. DOI: 10.1007/s00198-019-05098-0.
  • Legarth, C; Grimm, D; Kruger, M; Infanger, M; Wehland, M. Potential Beneficial Effectsof Vitamin D in Coronary Artery Disease. Nutrients. 2019, 12(1), 99. DOI: 10.3390/nu12010099.
  • Saponaro, F.; Marcocci, C.; Zucchi, R. Vitamin D Status and Cardiovascular Outcome. J. Endocrinol. Invest. 2019, 42(11), 1285–1290. DOI: 10.1007/s40618-019-01057-y.
  • Cioffi, G.; Gatti, D.; Adami, S. Vitamin D Deficiency, Left Ventricular Dysfunction and Heartfailure. G. Ital. Cardiol (Rome). 2010, 11(9), 645–653.
  • Amen, S. O.; Baban, S. T. Association of Vitamin D Deficiency with Acute MyocardialInfarction in Iraqi Patients. Eur. Cardiol. 2020, 15, e29. DOI: 10.15420/ecr.2020.15.1.PO6.
  • Hausenloy, D. J; Yellon, D. M. Myocardial Ischemia-reperfusion Injury: A Neglected Therapeutictarget. J. Clin. Invest. 2013, 123(1), 92–100. DOI: 10.1172/JCI62874.
  • Verdoia, M.; Nardin, M.; Rolla, R.; Negro, F.; Gioscia, R.; Afifeh, A. M. S.; Viglione, F.; Suryapranata, H.; Marcolongo, M.; De Luca, G. Novara Atherosclerosis Study G: Prognostic Impact of Vitamin D Deficiency in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Eur. J. Intern. Med. 2020, 83(1), 62–67.
  • Bischoff-Ferrari, H. A.; Dawson-Hughes, B.; Staehelin, H. B.; Orav, J. E.; Stuck, A. E.; Theiler, R.; Wong, J. B.; Egli, A.; Kiel, D. P.; Henschkowski, J. Fall Prevention with Supplementaland Active Forms of Vitamin D: A Meta-analysis of Randomised Controlled Trials. BMJ. 2009, 339, b3692.
  • Braun, L. A; Spitzer, O; Levkovich, B; Bailey, M; Stanguts, C; Hose, L.; Rosenfeldt, F. Prevalence of Vitamin D Deficiency Prior to Cardiothoracic Surgery. Heart. Lung. Circ. 2014, 23(10), 978–980. DOI: 10.1016/j.hlc.2014.03.014.
  • Sen, F; Yilmaz, S; Balci, K. G; Sen, O; Gul, M; Cay, S; Topaloglu, S; Aydogdu, S. Therelationship between Vitamin D Levels and Saphenous Vein Graft Patency. Coron. Artery.Dis. 2015, 26(4), 328–332. DOI: 10.1097/MCA.0000000000000240.
  • Zarei, M; Najafi, M; Movahedi, E; Javanbakht, M. H; Choi, Y. H; Yaseri, M; Shirvani, A; Sellke, F. W; Stranges, S. The Predictive Role of Circulating Telomerase and Vitamin Dforlong-term Survival in Patients Undergoing Coronary Artery Bypass Grafting Surgery (CABG). PLoS One. 2020, 15(8), e0237477. DOI: 10.1371/journal.pone.0237477.
  • Sheane, B. J; Smyth, P; Scott, K; Aziz, R; Buckley, M; Lodge, E; Kiely, N; Kingston, M; McGovern, E; Healy, M, et al. An Association betweenMicroRNA-21 Expression and Vitamin D Deficiency in Coronary Artery Disease. Microrna. 2015, 4(1), 57–63. DOI: 10.2174/2211536604666150414203919.
  • Rajasree, S.; Rajpal, K.; Kartha, C. C.; Sarma, P. S.; Kutty, V. R.; Iyer, C. S.; Girija, G. Serum25-hydroxyvitamin D3 Levels are Elevated in South Indian Patients with Ischemic Heartdisease. Eur. J. Epidemiol. 2001, 17(6), 567–571. DOI: 10.1023/A:1014559600042.
  • Linden, V. Vitamin D and Myocardial Infarction. Br. Med. J. 1974, 3(5932), 647–650. DOI: 10.1136/bmj.3.5932.647.
  • Kutty, V. R; Balakrishnan, K. G; Jayasree, A. K; Thomas, J. Prevalence of Coronary Heartdisease in the Rural Population of Thiruvananthapuram District, Kerala, India. Int.J. Cardiol. 1993, 39(1), 59–70. DOI: 10.1016/0167-5273(93)90297-T.
  • Tasdighi, E.; Hekmat, M.; Beheshti, M.; Baghaei, R.; Mirhosseini, S. M.; Torbati, P.; Pourmotahari, F.; Foroughi, M. Vitamin D Treatment Attenuates Heart ApoptosisAfter Coronary Artery Bypass Surgery: A Double-Blind, Randomized, Placebo-ControlledClinical Trial. J. Cardiovasc. Pharmacol. Ther. 2020, 25(4), 338–345. DOI: 10.1177/1074248420920495.
  • Cerit, L.; Ozcem, B.; Cerit, Z.; Duygu, H. Preventive Effect of Preoperative Vitamin DSupplementation on Postoperative Atrial Fibrillation. Braz. J. Cardiovasc. Surg. 2018, 33(1), 347–352. DOI: 10.21470/1678-9741-2018-0014.
  • Kara, H; Yasim, A. Effects of High-dose Vitamin D Supplementation on the Occurrence Ofpost-operative Atrial Fibrillation after Coronary Artery Bypass Grafting: Randomized Controlledtrial. Gen. Thorac. Cardiovasc.Surg. 2020, 68(5), 477–484. DOI: 10.1007/s11748-019-01209-0.
  • Yao, T. B; Ying, X. Y; Zhao, Y. C; Yuan, A. C; He, Q; Tong, H; Ding, S; Liu, J. L.; Peng, X.; Gao, E. H., et al. Vitamin D Receptor Activation Protects against MyocardialReperfusionInjury through Inhibition of Apoptosis and Modulation of Autophagy. Antioxid. Redox Signaling. 2015, 22(8), 633–650. DOI: 10.1089/ars.2014.5887.
  • Wu, Y.; Liu, F.; Ma, X.; Adi, D.; Gai, M. T.; Jin, X.; Yang, Y. N.; Huang, Y.; Xie, X.; Li, X. M., et al. iTRAQ Analysis of a Mouse Acute Myocardial Infarction Model Reveals thatvitaminD Binding Protein Promotes Cardiomyocyte Apoptosis after Hypoxia. Oncotarget. 2018, 9(2), 1969–1979.
  • Diez, E. R; Altamirano, L. B; Garcia, I. M; Mazzei, L; Prado, N. J; Fornes, M. W; Carrion, F. D; Zumino, A. Z; Ferder, L; Manucha, W. Heart Remodeling Andischemia-reperfusion Arrhythmias Linked to Myocardial Vitamin D Receptorsdeficiency in Obstructive Nephropathy are Reversed by Paricalcitol. J. CardiovascPharmacol. Ther. 2015, 20(2), 211–220.
  • Zhou, C. N.; Yao, W.; Gong, Y. N.; Li, Y.; Wang, C. H.; Huo, Y. F. 22-oxacalcitriolprotects Myocardial Ischemia-reperfusion Injury by Suppressing NF-kappaB/TNF-alpha Pathway. Eur. Rev. Med. Pharmacol. Sci. 2019, 23(12), 5495–5502. DOI: 10.26355/eurrev_201906_18219.
  • Hobuss, L; Foinquinos, A; Jung, M; Kenneweg, F; Xiao, K; Wang, Y; Zimmer, K.; Remke, J.; Just, A.; Nowak, J., et al. Pleiotropic Cardiac Functions Controlled by Ischemia-induced lncRNA H19. J. Mol.Cell. Cardiol. 2020, 146, 43–59. DOI: 10.1016/j.yjmcc.2020.07.001.
  • Qian, X; Zhu, M; Qian, W; Song, J. Vitamin D Attenuates Myocardial Ischemia-reperfusion Injury by Inhibiting Inflammation via Suppressing the RhoA/ROCK/NF-kB Pathway. Biotechnol. Appl. Biochem. 2019, 66(5), 850–857. DOI: 10.1002/bab.1797.
  • Lee, T. L; Lee, M. H; Chen, Y. C; Lee, Y. C; Lai, T. C; Lin, H. Y; Hsu, L. F; Sung, H. C.; Lee, C. W.; Chen, Y. L. Vitamin D Attenuates Ischemia/Reperfusion-InducedCardiac Injury by Reducing Mitochondrial Fission and Mitophagy. Front.Pharmacol. 2020, 11, 604700.
  • Safari, F; Zarei, F; Shekarforoush, S; Fekri, A; Klishadi, M. S; Hekmati- Moghaddam, S. Combined 1,25-Dihydroxy-vitamin D and Resveratrol: A Novel Therapeutic Approacto Ameliorate Ischemia Reperfusion-Induced Myocardial Injury. Int. J. Vitam. Nutr. Res. 2015, 85, 174–184. DOI: 10.1024/0300-9831/a000236.
  • Salvadori, M; Rosso, G; Bertoni, E. Update on Ischemia-reperfusion Injury in Kidneytransplantation: Pathogenesis and Treatment. World. J. Transplant. 2015, 5(2), 52–67. DOI: 10.5500/wjt.v5.i2.52.
  • Le Clef, N.; Verhulst, A.; D’Haese, P. C.; Vervaet, B. A. Unilateral Renal Ischemia-Reperfusionas a Robust Model for Acute to Chronic Kidney Injury in Mice. PLoS One. 2016, 11(3), e0152153. DOI: 10.1371/journal.pone.0152153.
  • Chertow, G. M; Burdick, E; Honour, M; Bonventre, J. V; Bates, D. W. Acute Kidney Injury,mortality, Length of Stay, and Costs in Hospitalized Patients. J. Am. Soc. Nephrol. 2005, 16(11), 3365–3370. DOI: 10.1681/ASN.2004090740.
  • Bonventre, J. V; Yang, L. Cellular Pathophysiology of Ischemic Acute Kidney Injury. J. Clin.Invest. 2011, 121(11), 4210–4221. DOI: 10.1172/JCI45161.
  • Kiersztejn, M.; Wiecek, A.; Kokot, F.; Schmidt-Gayk, H.; Wystrychowski, A.; Kuczera, M. Levels of 1,25-dihydroxyvitamin D3 Concentration in Renal Venous Blood Serum of Patientswith Renovascular Hypertension Caused by Unilateral Renal Artery Stenosis. Pol. Arch. Med.Wewn. 1998, 99(4), 281–286.
  • de Braganca, A. C.; Volpini, R. A.; Mehrotra, P.; Andrade, L.; Basile, D. P. Vitamin D Deficiencycontributes to Vascular Damage in Sustained Ischemic Acute Kidney Injury. Physiol. Rep. 2016, 4(13), e12829. DOI: 10.14814/phy2.12829.
  • de Braganca, A. C.; Volpini, R. A.; Canale, D.; Goncalves, J. G.; Shimizu, M. H.; Sanches, T. R.; Seguro, A. C.; Andrade, L. Vitamin D Deficiency Aggravates Ischemic Acute Kidney Injury Inrats. Physiol. Rep. 2015, 3(3), e12331. DOI: 10.14814/phy2.12331.
  • Silva Barbosa, A. C.; Zhou, D.; Xie, Y.; Choi, Y. J.; Tung, H. C.; Chen, X.; Xu, M.; Gibbs, R. B.; Poloyac, S. M.; Liu, S., et al. Inhibition of EstrogenSulfotransferase (SULT1E1/EST) Ameliorates Ischemic Acute Kidney Injury in Mice. J. Am.Soc. Nephrol. 2020, 31(7), 1496–1508. DOI: 10.1681/ASN.2019080767.
  • Meurer, M; Hocherl, K. Renal Ischemia-reperfusion Injury Impairs Renal Calcium, Magnesium,and Phosphate Handling in Mice. Pflugers. Arch. 2019, 471(6), 901–914. DOI: 10.1007/s00424-019-02255-6.
  • Goncalves, J. G; de Braganca, A. C; Canale, D; Shimizu, M. H; Sanches, T. R; Moyses, R. M; Andrade, L; Seguro, A. C; Volpini, R. A. Vitamin D Deficiency Aggravates Chronic Kidneydisease Progression after Ischemic Acute Kidney Injury. PLoS One. 2014, 9(9), e107228. DOI: 10.1371/journal.pone.0107228.
  • Kuro-o, M. Klotho, Phosphate and FGF-23 in Ageing and Disturbed Mineral Metabolism. Nat.Rev. Nephrol. 2013, 9(11), 650–660. DOI: 10.1038/nrneph.2013.111.
  • Kim, Y. O; Li, C; Sun, B. K; Kim, J. S; Lim, S. W; Choi, B. S; Kim, Y. S; Kim, J; Bang, B. K; Yang, C. W. Preconditioning with 1,25-dihydroxyvitamin D3 Protects against Subsequentischemia-reperfusion Injury in the Rat Kidney. Nephron. Exp. Nephrol. 2005, 100(2), e85–94. DOI: 10.1159/000084574.
  • Hwang, H. S; Yang, K. J; Park, K. C; Choi, H. S; Kim, S. H; Hong, S. Y; Jeon, B. H; Chang, Y. K.; Park, C. W.; Kim, S. Y., et al. Pretreatment with Paricalcitol Attenuatesinflammation in Ischemia-reperfusion Injury via the Up-regulation of Cyclooxygenase-2 Andprostaglandin E2. Nephrol. Dial. Transplant. 2013, 28(5), 1156–1166. DOI: 10.1093/ndt/gfs540.
  • Sinanoglu, O; Sezgin, G; Ozturk, G; Tuncdemir, M; Guney, S; Aksungar, F. B; Yener, N. Melatonin with 1,25-dihydroxyvitamin D3 Protects against Apoptotic Ischemia-reperfusion Injury in the Rat Kidney. Ren. Fail. 2012, 34(8), 1021–1026. DOI: 10.3109/0886022X.2012.700887.
  • Sezgin, G; Ozturk, G; Guney, S; Sinanoglu, O; Tuncdemir, M. Protective Effect of Melatoninand 1,25-dihydroxyvitamin D3 on Renal Ischemia-reperfusion Injury in Rats. Ren. Fail. 2013, 35(3), 374–379. DOI: 10.3109/0886022X.2012.760409.
  • Lee, J. W.; Kim, S. C.; Ko, Y. S.; Lee, H. Y.; Cho, E.; Kim, M. G.; Jo, S. K.; Cho, W. Y.; Kim, H. K. Renoprotective Effect of Paricalcitol via a Modulation of the TLR4-NF-kappaB Pathway Inischemia/reperfusion-induced Acute Kidney Injury. Biochem. Biophys. Res. Commun. 2014, 444(2), 121–127. DOI: 10.1016/j.bbrc.2014.01.005.
  • Ersan, S; Celik, A; Tanrisev, M; Kose, I; Cavdar, Z; Unlu, M; Kocak, A; Ural, C; Yilmaz, B.; Kose, T. Pretreatment with Paricalcitol Attenuates Level and Expression of Matrixmetalloproteinases in a Rat Model of Renal Ischemia-reperfusion Injury. Clin. Nephrol. 2017, 88(11), 231–238. DOI: 10.5414/CN109121.
  • Hong, Y. A.; Yang, K. J.; Jung, S. Y.; Park, K. C.; Choi, H.; Oh, J. M.; Lee, S. J.; Chang, Y. K.; Park, C. W.; Yang, C. W., et al. Paricalcitol Pretreatment Attenuates RenalIschemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway. Oxid. Med. Cell.Longev. 2017, 2017, 5031926. DOI: 10.1155/2017/5031926.
  • Hamzawy, M; Gouda, S. A. A; Rashed, L; Morcos, M. A; Shoukry, H; Sharawy, N. 22-oxacalcitriol Prevents Acute Kidney Injury via Inhibition of Apoptosis and Enhancement Ofautophagy. Clin. Exp. Nephrol. 2019, 23(1), 43–55. DOI: 10.1007/s10157-018-1614-y.
  • Azak, A; Huddam, B; Haberal, N; Kocak, G; Ortabozkoyun, L; Senes, M; Akdogan, M. F; Denizli, N; Duranay, M. Effect of Novel Vitamin D Receptor Activator Paricalcitol on Renalischaemia/reperfusion Injury in Rats. Ann. R. Coll. Surg. Engl. 2013, 95(7), 489–494. DOI: 10.1308/003588413X13629960049117.
  • Kapil, A.; Singh, J. P.; Kaur, T.; Singh, B.; Singh, A. P. Involvement of Peroxisome Proliferator-activated Receptor Gamma in Vitamin D-mediated Protection against Acute Kidney Injury in Rats. J. Surg. Res. 2013, 185(2), 774–783. DOI: 10.1016/j.jss.2013.07.017.
  • Li, J; Xu, S; Zhu, J. B; Song, J; Luo, B; Song, Y. P; Zhang, Z. H; Chen, Y. H; Zhang, Z. Q; Xie, D. D, et al. Pretreatment with Cholecalciferol Alleviates Renal CellularStress Response during Ischemia/Reperfusion-Induced Acute Kidney Injury. OxidativeMedicine and Cellular Longevity .2019, 2019, 1897316.
  • Ali, R. M; Al-Shorbagy, M. Y; Helmy, M. W; El-Abhar, H. S. Role of Wnt4/beta-catenin, AngII/TGFbeta, ACE2, NF-kappaB, and IL-18 in Attenuating Renal Ischemia/reperfusion-inducedinjury in Rats Treated with Vit D and Pioglitazone. Eur. J. Pharmacol. 2018, 831, 68–76. DOI: 10.1016/j.ejphar.2018.04.032.
  • Arfian, N; Budiharjo, S; Wibisono, D. P; Setyaningsih, W. A. W; Romi, M. M; Saputri, R; Rofiah, E. K; Rahmanti, T; Agustin, M; Sari, D. C. R. Vitamin D Ameliorates Kidney IschemiaReperfusion Injury via Reduction of Inflammation and Myofibroblast Expansion.Kobe. J.Med. Sci. 2020, 65(4), E138–E143.
  • Golmohammadi, M. G.; Banaei, S.; Nejati, K.; Chinifroush-Asl, M. M. Vitamin D3 Anderythropoietin Protect against Renal Ischemia-reperfusion Injury via Heat Shock Protein 70 andmicroRNA-21 Expression. Sci. Rep. 2020, 10(1), 20906. DOI: 10.1038/s41598-020-78045-3.
  • Dos Santos, M. S.; Canale, D.; Bernardo, D. R. D.; Shimizu, M. H. M.; Seguro, A. C.; Volpini, R. A.; de Braganca, A. C. The Restoration of Vitamin D Levels Slows the Progression of Renalschemic Injury in Rats Previously Deficient in Vitamin D.Front. Med (Lausanne). 2021, 8, 625647.
  • Pegah, E; Manouchehr, H; Mahmoud, B; Ramin, B; Seyed, M. M; Fatemeh, P; Seyed, A. Z; Mahnoosh, F. A. Randomized,Double-Blind,Placebo-Controlled, Clinical Trial of High-Dose, Short-Term Vitamin D Administration in the Prevention of Acute Kidney Injury after Cardiac Surgery. Cardiorenal Med. 2021, 11(1), 52–58. DOI: 10.1159/000511058.
  • Parra, C; Salas, P; Dominguez, J. Effects of Immunosuppressive Drugs on Rat Renal Ischemiareperfusion Injury. Transplant. Proc. 2010, 42(1), 245–247. DOI: 10.1016/j.transproceed.2009.11.018.
  • Douzinas, E. E; Livaditi, O; Tasoulis, M. K; Prigouris, P; Bakos, D; Goutas, N; Vlachodimitropoulos, D; Andrianakis, I; Betrosian, A; Tsoukalas, G. D. Nitrosative Andoxidative Stresses Contribute to Post-ischemic Liver Injury following Severe Hemorrhagic Shock:the Role of Hypoxemic Resuscitation. PLoS One. 2012, 7(3), e32968. DOI: 10.1371/journal.pone.0032968.
  • Arkadopoulos, N.; Defterevos, G.; Nastos, C.; Papalois, A.; Kalimeris, K.; Papoutsidakis, N.; Kampouroglou, G.; Kypriotis, D.; Pafiti, A.; Kostopanagiotou, G., et al. Development of a Porcine Model of Post-hepatectomy Liver Failure. J. Surg. Res. 2011, 170(2), e233–242. DOI: 10.1016/j.jss.2011.06.006.
  • Jaeschke, H. Molecular Mechanisms of Hepatic Ischemia-reperfusion Injury Andpreconditioning. Am J Physiol-Gastrointestinal Liver Physiol. 2003, 284(1), G15–G26. DOI: 10.1152/ajpgi.00342.2002.
  • Cannistra, M.; Ruggiero, M.; Zullo, A.; Gallelli, G.; Serafini, S.; Maria, M.; Naso, A.; Grande, R.; Serra, R.; Nardo, B. Hepatic Ischemia Reperfusion Injury: A Systematic Review of Literatureand the Role of Current Drugs and Biomarkers. Int. J. Surg. 2016, 33(Suppl 1), S57–70. DOI: 10.1016/j.ijsu.2016.05.050.
  • Bjelakovic, G.; Nikolova, D.; Bjelakovic, M.; Gluud, C. Vitamin D Supplementation Forchronic Liver Diseases in adults.Cochrane. Database. Syst. Rev. 2017, 11, CD011564.
  • Barchetta, I; Cimini, F. A; Cavallo, M. G. Vitamin D Supplementation and Non-AlcoholicFatty Liver Disease: Present and Future. Nutrients. 2017, 9(9), 1015. DOI: 10.3390/nu9091015.
  • Ferrándiz-Pulido, C.; Torres, I. B.; Juárez-Dobjanschi, C.; Zarzoso-Muñoz, I.; Berastegui, C.; Castells, L.; García-Patos, V.; Moreso, F. Vitamin D Deficiency in Solid-organ Transplant Recipientsfrom a Spanish Mediterranean Population. Clin. Exp. Dermatol. 2019, 44(4), e103–e109. DOI: 10.1111/ced.13915.
  • Seif, A. A; Abdelwahed, D. M. Vitamin D Ameliorates Hepatic Ischemic/reperfusion Injury Inrats. J. Physiol. Biochem. 2014, 70(3), 659–666. DOI: 10.1007/s13105-014-0335-2.
  • Yang, J.; Chen, Q.; Tian, S.; Song, S.; Liu, F.; Wang, Q.; Fu, Z. The Role of 1,25-dyhydroxyvitamin D3 in Mouse Liver Ischemia Reperfusion Injury: Regulation of Autophagythrough Activation of MEK/ERK Signaling and PTEN/PI3K/Akt/mTORC1 Signaling. Am. J.Transl. Res. 2015, 7(12), 2630–2645.
  • Kim, M. S; Lee, S; Jung, N; Lee, K; Choi, J; Kim, S. H; Jun, J; Lee, W. M; Chang, Y; Kim, D. The Vitamin D Analogue Paricalcitol Attenuates Hepatic Ischemia/reperfusion Injurythrough Down-regulation of Toll-like Receptor 4 Signaling in Rats. Archives of Medical Science. 2017, 13(2), 459–469. DOI: 10.5114/aoms.2016.60650.
  • Galkin, A. Brain Ischemia/Reperfusion Injury and Mitochondrial Complex I Damage. Biochemistry (Mosc). 2019, 84(11), 1411–1423. DOI: 10.1134/S0006297919110154.
  • Liang, T. Y; Peng, S. Y; Ma, M.; Li, H. Y; Wang, Z; Chen, G. Protective Effects of Sevofluranein Cerebral Ischemia Reperfusion Injury: A Narrative Review. Med. Gas. Res. 2021, 11(4), 152–154. DOI: 10.4103/2045-9912.318860.
  • Molinari, C; Morsanuto, V; Ghirlanda, S; Ruga, S; Notte, F; Gaetano, L; Uberti, F. Role ofCombined Lipoic Acid and Vitamin D3 on Astrocytes as a Way to Prevent Brain Ageing by Induced Oxidative Stress and Iron Accumulation. Oxid. Med. Cell. Longev. 2019, 2019, 2843121. DOI: 10.1155/2019/2843121.
  • Cui, X.; Gooch, H.; Petty, A.; McGrath, J. J.; Eyles, D. Vitamin D and the Brain: Genomic Andnon-genomic Actions. Mol. Cell. Endocrinol. 2017, 453, 131–143. DOI: 10.1016/j.mce.2017.05.035.
  • Sayeed, I; Turan, N; Stein, D. G; Wali, B. Vitamin D Deficiency Increases Blood-brain Barrierdysfunction after Ischemic Stroke in Male Rats. Exp. Neurol. 2019, 312, 63–71. DOI: 10.1016/j.expneurol.2018.11.005.
  • Balden, R; Selvamani, A; Sohrabji, F. Vitamin D Deficiency Exacerbates Experimental Strokeinjury and Dysregulates Ischemia-induced Inflammation in Adult Rats. Endocrinolog. 2012, 153(5), 2420–2435. DOI: 10.1210/en.2011-1783.
  • Daumas, A; Daubail, B; Legris, N; Jacquin-Piques, A; Sensenbrenner, B; Denimal, D; Lemaire-Ewing, S; Duvillard, L; Giroud, M; Bejot, Y. Association between AdmissionSerum 25-Hydroxyvitamin D Levels and Functional Outcome of Thrombolyzed StrokePatients. J. Stroke. Cerebrovasc. Dis. 2016, 25(4), 907–913. DOI: 10.1016/j.jstrokecerebrovasdis.2016.01.005.
  • Wei, L; Chen, C; Dai, Y. Q.; Ding, L.; Li, H. Y.; Lin, Y. J.; Wu, H. T.; Wu, Z.; Lu, Z. Q. Serum25-hydroxyvitamin D Deficiency Predicts Poor Outcomes among Acute Ischemic Strokepatients Receiving Intravenous Thrombolysis. Chinese Med. J. 2019, 132(4), 491–494. DOI: 10.1097/CM9.0000000000000084.
  • McGinn, E. A; Powers, A; Galas, M; Lyden, E; Peeples, E. S. Neonatal Vitamin D Status IsAssociated with the Severity of Brain Injury in Neonatal Hypoxic-Ischemic Encephalopathy:A Pilot Study. Neuropediatrics. 2020, 51(104), 251–258. DOI: 10.1055/s-0040-1708535.
  • Li, Y. Y; Wang, Y. S; Chen, Y; Hu, Y. H; Cui, W; Shi, X. Y; Jiang, W; Zhang, J. M. Association of Serum 25(OH)D Levels with Infarct Volumes and Stroke Severity inAcute Ischemic Stroke. Journal of Nutrition Health & Aging. 2018, 22(1), 97–102. DOI: 10.1007/s12603-017-0926-z.
  • Won, S; Sayeed, I; Peterson, B. L; Wali, B; Kahn, J. S; Stein, D. G. Vitamin D PreventsHypoxia/Reoxygenation-Induced Blood-Brain Barrier Disruption via Vitamin DReceptor-Mediated NF-kB Signaling Pathways. Plos One. 2015, 10(3), e0122821. DOI: 10.1371/journal.pone.0122821.
  • Atif, F; Yousuf, S; Espinosa-Garcia, C; Harris, W. A. C; Stein, D. G. Post-ischemic Strokesystemic Inflammation: Immunomodulation by Progesterone and Vitamin Dhormone. Neuropharmacology. 2020, 181, 108327. DOI: 10.1016/j.neuropharm.2020.108327.
  • Li, Y. R; Li, H. Protective Effects of Exogenous Vitamin D on Nerve Injury in Mice Withcerebral Ischemia/reperfusion. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2019, 35(4), 300–303. DOI: 10.12047/j.cjap.5794.2019.063.
  • Evans, M. A.; Kim, H. A.; Ling, Y. H.; Uong, S.; Vinh, A.; De Silva, T. M.; Arumugam, T. V.; Clarkson, A. N.; Zosky, G. R.; Drummond, G. R., et al. Vitamin D3Supplementation Reduces Subsequent Brain Injury and Inflammation Associated withIschemic Stroke. Neuromolecular. Med. 2018, 20(1), 147–159. DOI: 10.1007/s12017-018-8484-z.
  • Yuan, J; Guo, X; Liu, Z; Zhao, X; Feng, Y; Song, S; Cui, C; Jiang, P. Vitamin D Receptoractivation Influences the ERK Pathway and Protects against Neurological Deficits Andneuronal Death. Int. J. Mol. Med. 2018, 41(1), 364–372. DOI: 10.3892/ijmm.2017.3249.
  • Fu, J.; Xue, R.; Gu, J.; Xiao, Y.; Zhong, H.; Pan, X.; Ran, R. Neuroprotective Effect Ofcalcitriol on Ischemic/reperfusion Injury through the NR3A/CREB Pathways in the Rathippocampus. Mol. Med. Rep. 2013, 8(6), 1708–1714. DOI: 10.3892/mmr.2013.1734.
  • Atif, F; Yousuf, S; Sayeed, I; Ishrat, T; Hua, F; Stein, D. G. Combination Treatment Withprogesterone and Vitamin D Hormone Is More Effective than Monotherapy in Ischemic Stroke:the Role of BDNF/TrkB/Erk1/2 Signaling in Neuroprotection. Neuropharmacology. 2013, 67, 78–87. DOI: 10.1016/j.neuropharm.2012.10.004.
  • Kim, S. W.; Oh, J. S.; Park, J.; Jeong, H. H.; Oh, Y. M.; Choi, S.; Choi, K. H. Neuroprotectiveeffect of Paricalcitol in a Rat Model of Transient Global Cerebral Ischemia. Int. J. Emerg.Med. 2020, 13(1), 30. DOI: 10.1186/s12245-020-00289-7.
  • Guo, X; Yuan, J; Wang, J; Cui, C; Jiang, P. Calcitriol Alleviates Global Cerebral Ischemia-induced Cognitive Impairment by Reducing Apoptosis Regulated by VDR/ERK Signalingpathwayin Rat Hippocampus. Brain. Res. 2019, 1724, 146430. DOI: 10.1016/j.brainres.2019.146430.
  • Sadeghian, N.; Shadman, J.; Moradi, A.; Ghasem Golmohammadi, M.; Panahpour, H. Calcitriol Protects the Blood-Brain Barrier Integrity against Ischemic Stroke and Reducesvasogenic Brain Edema via Antioxidant and Antiapoptotic Actions in Rats. Brain. Res.Bull. 2019, 150, 281–289. DOI: 10.1016/j.brainresbull.2019.06.010.
  • Velimirovic, M.; Jevtic Dozudic, G.; Selakovic, V.; Stojkovic, T.; Puskas, N.; Zaletel, I.; Zivkovic, M.; Dragutinovic, V.; Nikolic, T.; Jelenkovic, A., et al. Effects of Vitamin D3 on the NADPH Oxidase and Matrix Metalloproteinase9 in an Animal Model of Global Cerebral Ischemia. Oxid. Med. Cell. Longev. 2018, 2018, 3273654. DOI: 10.1155/2018/3273654.
  • Ekici, F.; Ozyurt, B.; Erdogan, H. The Combination of Vitamin D3 and Dehydroascorbic Acidadministration Attenuates Brain Damage in Focal Ischemia. Neurol. Sci. 2009, 30(3), 207–212. DOI: 10.1007/s10072-009-0038-6.
  • Coselli, J. S; LeMaire, S. A; Conklin, L. D; Koksoy, C; Schmittling, Z. C. Morbidity Andmortality after Extent II Thoracoabdominal Aortic Aneurysm Repair. Ann. Thorac. Surg. 2002, 73(4), 1107–1115. discussion 1115-1106. DOI: 10.1016/S0003-4975(02)03370-2.
  • Faheem, H; Mansour, A; Elkordy, A; Rashad, S; Shebl, M; Madi, M; Elwy, S; Niizuma, K.; Tominaga, T. Neuroprotective Effects of Minocycline and Progesterone on White Mattinjury after Focal Cerebral Ischemia. J.Clin. Neurosci. 2019, 64, 206–213. DOI: 10.1016/j.jocn.2019.04.012.
  • Hentia, C; Rizzato, A; Camporesi, E; Yang, Z; Muntean, D. M; Sandesc, D; Bosco, G. Anoverview of Protective Strategies against Ischemia/reperfusion Injury: The Role of Hyperbaricoxygen Preconditioning. Brain.Behav. 2018, 8(5), e00959. DOI: 10.1002/brb3.959.
  • Karimipour, M; Farjah, G. H; Molazadeh, F; Ansari, M; Pourheidar, B. Protective Effect ofContralateral, Ipsilateral, and Bilateral Remote Ischemic Preconditioning on Spinal Cord Ischemia Reperfusion Injury in Rats. Turk. Neurosurg. 2019, 29(6), 933–939. DOI: 10.5137/1019-5149.JTN.26237-19.3.
  • Jia, X. F; Kowalski, R. G; Sciubba, D. M; Geocadin, R. G. Critical Care of Traumatic SpinalCord Injury. Journal of Intensive Care Medicine. 2013, 28(1), 12–23. DOI: 10.1177/0885066611403270.
  • Gurer, B; Karakoc, A; Bektasoglu, P. K; Kertmen, H; Kanat, M. A; Arikok, A. T; Erguder, B. I.; Sargon, M. F.; Ozturk, O. C.; Celikoglu, E. Comparative Effects of Vitamin D Andmethylprednisolone against Ischemia/reperfusion Injury of Rabbit Spinal Cords. Eur.J .Pharmacol. 2017, 813, 50–60. DOI: 10.1016/j.ejphar.2017.07.028.
  • Martin, C. M. K. No Ovarian Torsion in a 20-Year-Old Patient. C.j.e.m. 2006, 8, 126–129.
  • Yildirim, N.; Simsek, D.; Kose, S.; Yildirim, A. G. S.; Guven, C.; Yigitturk, G.; Erbas, O. Theprotective Effect of Gingko Biloba in a Rat Model of Ovarian Ischemia/reperfusion injury:Improvement in Histological and Biochemical Parameters. Adv. Clin. Exp. Med. 2018, 27(5), 591–597. DOI: 10.17219/acem/68896.
  • Chen, Y.; Zhi, X. Roles of Vitamin D in Reproductive Systems and Assisted ReproductiveTechnology. Endocrinology. 2020, 161(4), bqaa023. DOI: 10.1210/endocr/bqaa023.
  • Tokgoz, V. Y.; Sipahi, M.; Keskin, O.; Guvendi, G. F.; Takir, S. Protective Effects of Vitamin Don Ischemia-reperfusion Injury of the Ovary in a Rat Model. Iran. J. Basic. Med. Sci. 2018, 21(6), 593–599. DOI: 10.22038/IJBMS.2018.26914.6581.
  • Definition of Infarction. In MedicineNet. April 27 2011. WebMD, (Charles P.D).
  • Nikolaos, G. F. Pathophysiology of Myocardial Infarction. Compr. Physiol. 2015, 5(4), 1841–1875. DOI: 10.1002/cphy.c150006.
  • Suresh, S; Michael, D. H. Massive Cerebral Infarction. Neurologist. 2005, 11(3), 150–160. DOI: 10.1097/01.nrl.0000159987.70461.d7.
  • David, A. T. Acute Intestinal Ischemia and Infarction Semin . Gastrointest Dis. 2003, 14(2), 66–76.
  • Akkus, O.; Topuz, M.; Oz, F.; Harbalioglu, H.; Koca, H.; Kaplan, M.; Sen, O.; Bulut, A.; Gur, M. Impact of 25(OH)D3 on Spontaneous Reperfusion and SYNTAX Score Inpatients withST-elevation Myocardial Infarction. Turk. Kardiyol. Dern. Ars. 2018, 46(4), 268–275.
  • Scragg, R.; Jackson, R.; Holdaway, I.; Woollard, G.; Woollard, D. Changes in Plasmavitamin Levels in the First 48 Hours after Onset of Acute Myocardial Infarction. Am. J. Cardiol. 1989, 64(16), 971–974. DOI: 10.1016/0002-9149(89)90792-3.
  • Barth, J. H.; Field, H. P.; Mather, A. N.; Plein, S. Serum 25 Hydroxy-vitamin D Does Not Exhibitan Acute Phase Reaction after Acute Myocardial Infarction. Ann. Clin.Biochem. 2012, 49(Pt4), 399–401. DOI: 10.1258/acb.2011.011195.
  • Verdoia, M.; Ceccon, C.; Nardin, M.; Suryapranata, H.; De Luca, G.; Novara Atherosclerosisstudy, G. Vitamin D Deficiency and Periprocedural Myocardial Infarction in Patients Undergoingpercutaneous Coronary Interventions. Cardiovasc. Revasc. Med. 2018, 19(7 Pt A), 744–750. DOI: 10.1016/j.carrev.2018.03.002.
  • Aslanabadi, N; Jafaripor, I; Sadeghi, S; Hamishehkar, H; Ghaffari, S; Toluey, M.; Azizi, H.; Entezari-Maleki, T. Effect of Vitamin D in the Prevention of Myocardial InjuryFollowingElective Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial. J. Clin.Pharmacol. 2018, 58(2), 144–151. DOI: 10.1002/jcph.989.
  • Wang, Y; Chiang, Y. H; Su, T. P; Hayashi, T; Morales, M; Hoffer, B. J; Lin, S. Z. VitaminD(3) Attenuates Cortical Infarction Induced by Middle Cerebral Arterial Ligation in Rats. Neuropharmacology. 2000, 39(5), 873–880. DOI: 10.1016/S0028-3908(99)00255-5.
  • Bao, G. Q.; Yu, J. Y. Vitamin D3 Promotes Cerebral Angiogenesis after Cerebral Infarction Inrats by Activating Shh Signaling Pathway. Eur. Rev. Med. Pharmacol. Sci. 2018, 22(20), 7069–7077. DOI: 10.26355/eurrev_201810_16179.